Establishment and characterization of three new breast-cancer cell lines
- PMID: 9610725
- DOI: 10.1002/(sici)1097-0215(19980529)76:5<677::aid-ijc11>3.0.co;2-1
Establishment and characterization of three new breast-cancer cell lines
Abstract
We have established and characterized 3 new breast-cancer cell lines from pleural effusions of patients with advanced breast cancer. All 3 cell lines, designated IBEP-1, IBEP-2 and IBEP-3, showed typical ultrastructural characteristics of epithelial mammary tumor cells. Electron microscopy showed, among other characteristics, the presence of numerous microvilli, desmosomal junctions, intracytoplasmic duct-like vacuoles, well-developed endoplasmic reticulum and large nuclei. Immunohistochemical and biochemical studies revealed that the 3 cell lines expressed cytokeratin, epithelial membrane antigen, CEA and CA 15-3, but all showed negative immunoreaction for vimentin. On the other hand, other antigens (LEU-M1, GCDFP 15, c-erbB-2) were expressed by some of the cell lines, but in a variable manner. Ploidy studies confirmed the neoplastic origin of the cell lines. The doubling times were 68 hr for IBEP-1, 29 hr for IBEP-2 and 39 hr for IBEP-3. Only IBEP-2 cells expressed estrogen receptors (ER+), which were down-regulated after preincubation with E2, but they did not express progesterone receptors (PgR-). IBEP-1 and IBEP-3 cells were ER- but expressed PgR (PgR+). In these 2 cell lines, PgR were down-regulated after pre-incubation of the cells with progesterone (10(-8) M) for 24 hr. Estradiol (E2) increased the proliferation rate of IBEP-2 cells and progesterone increased the proliferation of IBEP-I and -3 cell lines. S.C. injection of the 3 IBEP cell lines into nude mice resulted in the growth of solid tumors between 11 and 16 weeks after inoculation. These cell lines could thus be new models for studying various aspects of the biology and the tumorigenicity of breast-cancer cells. A major interest of these new cell lines is that 2 of them were ER- and PgR+, which is an exceptional phenotypic feature. These 2 cell lines could be interesting models for studying the regulation of PgR and the effects of progestins and antiprogestins independently of the presence of ER.
Similar articles
-
Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma.Breast Cancer Res Treat. 2004 Jul;86(1):39-53. doi: 10.1023/B:BREA.0000032922.87541.31. Breast Cancer Res Treat. 2004. PMID: 15218360
-
Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice.Breast Cancer Res Treat. 1997 May;43(3):247-58. doi: 10.1023/a:1005756632293. Breast Cancer Res Treat. 1997. PMID: 9150904
-
Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization.Anticancer Res. 1992 May-Jun;12(3):683-92. Anticancer Res. 1992. PMID: 1377894
-
Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?Cancer Treat Rev. 2018 Jun;67:78-87. doi: 10.1016/j.ctrv.2018.05.005. Epub 2018 May 16. Cancer Treat Rev. 2018. PMID: 29772460 Review.
-
Hormone receptors and Japanese breast cancer.Acta Pathol Jpn. 1982;32 Suppl 1:145-54. Acta Pathol Jpn. 1982. PMID: 6764994 Review.
Cited by
-
Characterization of ductal carcinoma in situ cell lines established from breast tumor of a Singapore Chinese patient.Cancer Cell Int. 2014 Sep 20;14(1):94. doi: 10.1186/s12935-014-0094-8. eCollection 2014. Cancer Cell Int. 2014. PMID: 25264427 Free PMC article.
-
Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.Br J Cancer. 2004 Nov 1;91(9):1703-10. doi: 10.1038/sj.bjc.6602181. Br J Cancer. 2004. PMID: 15477866 Free PMC article.
-
Failure to progress: breast and prostate cancer cell lines in developing targeted therapies.Cancer Metastasis Rev. 2024 Dec;43(4):1529-1548. doi: 10.1007/s10555-024-10202-w. Epub 2024 Jul 26. Cancer Metastasis Rev. 2024. PMID: 39060878 Review.
-
Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.Breast Cancer Res. 2006;8(1):R2. doi: 10.1186/bcr1363. Epub 2005 Dec 12. Breast Cancer Res. 2006. PMID: 16417650 Free PMC article.
-
Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis.Cancer Cell Int. 2014 Feb 5;14(1):14. doi: 10.1186/1475-2867-14-14. Cancer Cell Int. 2014. PMID: 24502646 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous